Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Demystified...recombinant antibodies.

K A Smith1, P N Nelson, P Warren

  • 1Division of Cell and Molecular Medicine, Postgraduate Medical Institute, University of Hull, Cottingham Rd, Hull HU6 7RX, UK. k.a.smith@hull.ac.uk

Journal of Clinical Pathology
|August 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of microbial fuel cell operation time on the disinfection efficacy of electrochemically synthesised catholyte from urine.

Process biochemistry (Barking, London, England)·2021
Same author

Evaluation of artificial neural network algorithms for predicting the effect of the urine flow rate on the power performance of microbial fuel cells.

Energy (Oxford, England)·2020
Same author

Modelling the energy harvesting from ceramic-based microbial fuel cells by using a fuzzy logic approach.

Applied energy·2019
Same author

Response of ceramic microbial fuel cells to direct anodic airflow and novel hydrogel cathodes.

International journal of hydrogen energy·2019
Same author

A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens.

Scientific reports·2019
Same author

A New Method for Modulation, Control and Power Boosting in Microbial Fuel Cells.

Fuel cells (Weinheim)·2019
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026
Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026
See all related articles

Recombinant antibodies, including phage antibodies, are valuable research tools. This article explains their generation and potential clinical applications in diagnostics and therapeutics.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Recombinant antibodies are crucial for biomedical research and clinical applications.
  • Humanized antibodies and antibody fragments, such as single chain variable fragments (scFv), are key developments.
  • Phage antibody fragments are gaining popularity due to established generation methods.

Purpose of the Study:

  • To provide a background on humanized antibodies and antibody fragment generation.
  • To explain the methodology and advantages of phage antibody fragments.
  • To explore the potential applications of phage antibodies in pathology and clinical settings.

Main Methods:

  • Generation of antibody fragments, including single chain Fv fragments.
  • Utilizing phage display methodology for affinity enrichment of antibody fragments.

Related Experiment Videos

  • Affinity enrichment from libraries derived from immune cells.

    • Main Results:

    • Phage antibody fragments can be generated using established affinity enrichment methods.
    • Phage display enhances the affinity of existing antibody fragments.
    • The article demystifies phage antibodies, highlighting their potential.

    Conclusions:

    • Phage antibodies offer significant potential as diagnostic and therapeutic reagents.
    • Understanding phage antibody technology can drive innovation in clinical settings.
    • Biomedical scientists and clinicians should consider the applications of phage antibodies.